San Diego, CA, United States of America

Lino Valdez

This inventor holds 2 USPTO granted patents and 1 published patent application and 3 EPO patents. Top assignees: Dart Neuroscience, LLC, Vertex Pharmaceuticals, Inc.. Active years: 2025-2026.

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 12.6

ph-index = 1


Company Filing History:


Years Active: 2025-2026

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Lino Valdez: Innovator in Cystic Fibrosis Treatment

Introduction

Lino Valdez is a notable inventor based in San Diego, California. He has made significant contributions to the field of pharmaceutical sciences, particularly in the treatment of cystic fibrosis. His work focuses on developing modulators for the cystic fibrosis transmembrane conductance regulator (CFTR), which plays a crucial role in the disease.

Latest Patents

Lino Valdez holds a patent for "Modulators of Cystic Fibrosis Transmembrane Conductance Regulator." This patent provides essential information on modulators of CFTR, pharmaceutical compositions containing these modulators, methods for treating cystic fibrosis, and processes for creating these modulators. His innovative approach aims to improve the quality of life for individuals affected by this condition.

Career Highlights

Valdez is currently employed at Vertex Pharmaceuticals, Inc., a leading company in the development of therapies for cystic fibrosis and other serious diseases. His work at Vertex has allowed him to collaborate with other talented professionals in the field, enhancing the impact of his research.

Collaborations

Some of Lino Valdez's coworkers include Jeremy J. Clemens and William Schulz Bechara. Their combined expertise contributes to the advancement of treatments for cystic fibrosis and other related conditions.

Conclusion

Lino Valdez is a dedicated inventor whose work in developing CFTR modulators represents a significant advancement in cystic fibrosis treatment. His contributions to the pharmaceutical industry continue to pave the way for innovative therapies that can improve patient outcomes.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…